Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-10-25

Clinical Trial Update: Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update on treatments for exudative and vasogenic chorioretinal diseases including AMD variants and other CNV-related maculopathies; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Manhattan Eye, Ear & Throat Hospital | Conditions: Coats' Disease, Idiopathic Retinal Telangiectasia | Phase 1, Phase 2 | Status: COMPLETED